SLC11A1 as a stratification indicator for immunotherapy or chemotherapy in patients with glioma

SLC11A1 as a stratification indicator for immunotherapy or chemotherapy in patients with glioma

BackgroundGlioma is a fatal tumor originating from the brain, which accounts for most intracranial malignancies. Currently, Immunotherapy has turned into a novel and promising treatment in glioma patients. however, there are still few effective biomarkers to mirror the reaction to immunotherapy in p...

Full description

Bibliographic Details
Main Authors:	Houshi Xu, Anke Zhang, Chaoyou Fang, Qingwei Zhu, Wei Wang, Yibo Liu, Zeyu Zhang, Xiaoyu Wang, Ling Yuan, Yuanzhi Xu, Anwen Shao, Meiqing Lou
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-11-01
Series:	Frontiers in Immunology
Subjects:	glioma immunotherapy biomarker immune infiltration prognosis
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.980378/full

Similar Items

TRP Family Genes Are Differently Expressed and Correlated with Immune Response in Glioma
by: Chaoyou Fang, et al.
Published: (2022-05-01)

URB2 as an important marker for glioma prognosis and immunotherapy
by: Chaoyou Fang, et al.
Published: (2023-03-01)

Prognosis Analysis and Validation of m6A Signature and Tumor Immune Microenvironment in Glioma
by: Shaojian Lin, et al.
Published: (2020-10-01)

Prognostic and predictive value of FCER1G in glioma outcomes and response to immunotherapy
by: Houshi Xu, et al.
Published: (2021-02-01)

Anoikis resistance in diffuse glioma: The potential therapeutic targets in the future
by: Zhengyang Zhu, et al.
Published: (2022-08-01)

Ferroptosis in glioma treatment: Current situation, prospects and drug applications
by: Yuhang Zhou, et al.
Published: (2022-09-01)

Natural Products for the Treatment of Post-stroke Depression
by: Chaoyou Fang, et al.
Published: (2022-05-01)

Immune Infiltration-Related Signature Predicts Risk Stratification and Immunotherapy Efficacy in Grade II and III Gliomas
by: Cong Luo, et al.
Published: (2021-11-01)

Spotlight on clinical strategies of Chronic Internal Carotid Artery Occlusion: Endovascular interventions and external-intracarotid bypasses compared to conservative treatment
by: Junnan Wu, et al.
Published: (2022-11-01)

Deciphering the role of QPCTL in glioma progression and cancer immunotherapy
by: Yu’e Liu, et al.
Published: (2023-03-01)

Immune-related genes with APA in microenvironment indicate risk stratification and clinical prognosis in grade II/III gliomas
by: Shengchao Xu, et al.
Published: (2021-03-01)

Serine and glycine metabolism-related gene expression signature stratifies immune profiles of brain gliomas, and predicts prognosis and responses to immunotherapy
by: Siliang Chen, et al.
Published: (2022-11-01)

CCL17 exerts neuroprotection through activation of CCR4/mTORC2 axis in microglia after subarachnoid haemorrhage in rats
by: Sheng Chen, et al.

Co‐amplified with PDGFRA, IGFBP7 is a prognostic biomarker correlated with the immune infiltrations of glioma
by: Haiwei Wang, et al.
Published: (2023-02-01)

Prognostic Value of MEG3 and Its Correlation With Immune Infiltrates in Gliomas
by: Xiaoping Xu, et al.
Published: (2021-06-01)

Overexpression of TPM4 is associated with worse prognosis and immune infiltration in patients with glioma
by: Yao Li, et al.
Published: (2023-01-01)

Oncolytic viral therapy as promising immunotherapy against glioma
by: Die Hu, et al.
Published: (2023-12-01)

CCDC103 as a Prognostic Biomarker Correlated with Tumor Progression and Immune Infiltration in Glioma
by: Xu Z, et al.
Published: (2023-10-01)

Machine learning-based identification of SOX10 as an immune regulator of macrophage in gliomas
by: Gelei Xiao, et al.
Published: (2022-11-01)

2-(2,4-Dinitrophenyl)-1-(pyridin-4-yl)ethanol monohydrate
by: Houshi Huang, et al.
Published: (2021-02-01)

ABRACL as a potential prognostic biomarker and correlates with immune infiltration in low-grade gliomas
by: Bohan Liu, et al.
Published: (2022-12-01)

Machine learning-based investigation of regulated cell death for predicting prognosis and immunotherapy response in glioma patients
by: Wei Zhang, et al.
Published: (2024-02-01)

Functional characterization of TSPAN7 as a novel indicator for immunotherapy in glioma
by: Long Chen, et al.
Published: (2023-02-01)

TNFSF13 Is a Novel Onco-Inflammatory Marker and Correlates With Immune Infiltration in Gliomas
by: Rui Chen, et al.
Published: (2021-10-01)

Clusterin Is a Prognostic Biomarker of Lower-Grade Gliomas and Is Associated with Immune Cell Infiltration
by: Xiaoyue Ren, et al.
Published: (2023-08-01)

The PANoptosis-related signature indicates the prognosis and tumor immune infiltration features of gliomas
by: Jingjing Song, et al.
Published: (2023-07-01)

Construction and validation of an immune infiltration-related risk model for predicting prognosis and immunotherapy response in low grade glioma
by: Jinna Li, et al.
Published: (2023-08-01)

Fusions involving BCOR and CREBBP are rare events in infiltrating glioma
by: David J. Pisapia, et al.
Published: (2020-06-01)

CENPN Acts as a Novel Biomarker that Correlates With the Malignant Phenotypes of Glioma Cells
by: Hailong Wu, et al.
Published: (2021-09-01)

Glioma-associated microglia/macrophages (GAMs) in glioblastoma: Immune function in the tumor microenvironment and implications for immunotherapy
by: Chao Lin, et al.
Published: (2023-03-01)

CDC6 is a prognostic biomarker and correlated with immune infiltrates in glioma
by: Feng Wang, et al.
Published: (2022-07-01)

Clinical and Biological Significance of a Necroptosis-Related Gene Signature in Glioma
by: Zunjie Zhou, et al.
Published: (2022-06-01)

CENPA acts as a prognostic factor that relates to immune infiltrates in gliomas
by: Bo Wang, et al.
Published: (2022-10-01)

The expression of Hexokinase 2 and its hub genes are correlated with the prognosis in glioma
by: Yishan Huang, et al.
Published: (2022-08-01)

MELK is a prognostic biomarker and correlated with immune infiltration in glioma
by: Haiyan Yang, et al.
Published: (2022-10-01)

APOL4, a Novel Immune-Related Prognostic Biomarker for Glioma
by: Hua Zhu, et al.
Published: (2022-09-01)

TGIF2 is a potential biomarker for diagnosis and prognosis of glioma
by: Wan Zhang, et al.
Published: (2024-02-01)

Natural Products for the Immunotherapy of Glioma
by: Qi Huang, et al.
Published: (2023-06-01)

PDIA5 is Correlated With Immune Infiltration and Predicts Poor Prognosis in Gliomas
by: Hao Zhang, et al.
Published: (2021-02-01)

Cathepsin a upregulation in glioma: A potential therapeutic target associated with immune infiltration
by: Zhang Ming, et al.
Published: (2022-01-01)